Home About us Contact
|
Home About us Contact | ||
|
|
||
Subgingival Scaling (subgingival + scaling)
Selected AbstractsEffect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitisJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 10 2007Ana Belén Navarro-Sanchez Abstract Objetives: The purpose of this study was to compare the local efficacy of nonsurgical periodontal therapy between type 2 diabetic and non-diabetic patients and the effect of periodontal therapy on glycaemic control. Background: A complex two-way relationship exists between diabetes mellitus and periodontitis. Material and Methods: After selection, 20 subjects (10 diabetic and 10 non-diabetic) underwent baseline examination, periodontal clinical study and biochemical analysis of gingival crevicular fluid (GCF). After the pre-treatment phase, subgingival scaling and root planing were performed. Subsequently, all subjects continued the maintenance programme and were re-examined at 3 and 6 months. Results: Diabetic and non-diabetic subjects responded well after therapy, showing a very similar progression during the follow-up period. Both groups showed clinically and immunologically significant improvements. Significant reductions were also found in the total volume of GCF and levels of interleukin-1, and tumour necrosis factor- ,. Diabetic subjects showed an improvement in their metabolic control. The change in glycosylated haemoglobin (HbA1C) was statistically significant at 3 and 6 months. Conclusions: The clinical and immunological improvements obtained were accompanied by a significant reduction in HbA1C values in type 2 diabetic subjects. Larger studies are needed to confirm this finding and establish whether periodontal therapy has a significant effect on glycaemic control. [source] Effectiveness of periodontal therapy on the severity of cyclosporin A-induced gingival overgrowthJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 8 2005Mario Aimetti Abstract Aim: The purpose of the present study was to evaluate the clinical effects of aetiological periodontal treatment in a group of transplant patients medicated with cyclosporin A (CsA) who exhibited severe gingival overgrowth. Materials and Methods: Twenty-one patients received oral hygiene instructions, supra- and subgingival scaling and periodontal maintenance therapy and were monitored for 12 months. Full-mouth plaque score (FMPS), full-mouth bleeding score (FMBS), periodontal probing depth and degree of gingival overgrowth (Seymour index GO) were recorded at baseline, 6 and 12 months after treatment. Results: Statistical evaluation revealed that all clinical variables significantly decreased compared with baseline. At baseline 18 out of 21 treated patients (85.71%) exhibited clinically significant overgrowth. Initial GO score of 2.38±1.92 in the anterior sextants and of 1.29±1.59 in the posterior segments were reduced to 0.56±0.83 and to 0.45±0.84 at 12 months (p<0.001). A difference of 1.82 and 0.84 in the severity of treated GO was accompained by a 42% and 34% decrease in FMPS and FMBS, respectively. Conclusions: Aetiological periodontal treatment and regular maintenance therapy were effective in resolving the inflammation and in eliminating the need for surgical treatment in patients receiving CsA. [source] Eruption cyst formation associated with cyclosporin AJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 5 2003A case report Abstract Background: Cyclosporin A (CyA) is a potent immunomodulatory agent with a wide range of applications. Despite its therapeutic value, multiple adverse effects of CyA have been identified. This case report describes eruption cyst formation as a possible adverse effect of CyA administration during tooth eruption in a boy treated with CyA as a consequence of a cardiac transplantation. The clinical diagnosis of eruption cyst was confirmed by histopathological examination. Treatment: The periodontal treatment consisted of supragingival and subgingival scaling, followed by surgical removal of the tissues overlying the crowns of the teeth associated with eruption cysts, and flap surgery in the region of gingival overgrowth. The patient was then placed on quarterly periodontal supportive therapy and his immunosuppressive medication was switched from CyA to tacrolimus. Results: Twenty months after therapy, neither new cyst formation nor recurrence of gingival overgrowth was registered. Conclusion: Formation of an eruption cyst may be an adverse effect of CyA in children with erupting teeth. Zusammenfassung Hintergrund: Cyclosporin A (CyA) ist potentes immunmodulierendes Pharmakon mit einer breiten Applikationsmöglichkeit. Unabhängig von seinem therapeutischen Wert sind multiple Nebeneffekte von CyA beschrieben worden. Dieser Fallbericht beschreibt die Bildung einer Zyste beim Zahndurchbruch als eine mögliche Nebenwirkung von CyA Medikation bei einem Jungen, der mit CyA wegen einer Herztransplantation behandelt wurde. Die klinische Diagnose der Zystenbildung wurde histopathologisch bestätigt. Behandlung: Die parodontale Behandlung bestand in supragingivaler und subgingivaler Zahnreinigung gefolgt von der chirurgischen Entfernung des die Zahnkronen überdeckenden Gewebes, was mit der Zystenbildung verbunden war, und der Lappenchirurgie in der Region der gingivalen Wucherung. Der Patient wurde dann in das vierteljährliche parodontale Recall übernommen, und seine immunsuppressive Medikation wurde von CyA zu Tacrolimus verändert. Ergebnisse: 20 Monate nach der Therapie wurde weder eine neue Zystenbildung noch eine Wiederkehr der gingivalen Wucherung registriert. Schlussfolgerung: Die Bildung einer Durchbruchszyste kann eine Nebenwirkung bei der CyA Medikation bei Kindern während des Zahndurchbruchs sein. Résumé La cyclosporine A (CyA) est un agent immuno-modulateur puissant avec un large éventail d'applications. Malgré sa valeur thérapeutique, de multiples effets secondaires CyA ont été identifiés. Ce rapport de cas décrit une formation de kystes d'éruption qui pourrait être un effet secondaire possible de l'administration de CyA durant l'éruption dentaire chez un garçon traité par CyA à la suite d'une transplantation cardiaque. Le diagnostic clinique du kyste d'éruption a été confirmé par l'histopathologie. Le traitement parodontal a consisté en détartrage et surfaçage suivis par l'enlèvement chirurgical des tissus recouvrant les couronnes des dents associés aux kystes d'éruptions, et une chirurgie par lambeaux dans la région d'accroissement gingivale. L'enfant a bénéficié d'un suivi parodontal trimestriel et sa médication immunosuppressive est passée du CyA au tacrolimus. Vingt mois après le traitement, ni la formation de kystes ni la réapparition d'hypertrophie gingivale n'a été enregistrée. La formation de kystes d'éruption pourrait donc être un effet secondaire de l'utilisation de la CyA chez les enfants au moment de l'éruption des dents. [source] A comparison of root surface instrumentation using two piezoelectric ultrasonic scalers and a hand scaler in vivoJOURNAL OF PERIODONTAL RESEARCH, Issue 1 2007H. Kawashima Background and Objective:, This study compared the effectiveness of two piezoelectric ultrasonic scalers and a hand scaler for subgingival scaling and root planing in vivo. Material and Methods:, Fifteen patients with advanced periodontal disease and with teeth scheduled for extraction were selected for this study. Three experimental groups of 10 teeth each were treated with one of two piezoelectric ultrasonic scalers [VectorÔ scaler and Enac® scaler] or with a hand scaler. Instrumentation was continued until the root surface felt hard and smooth to an explorer tip. The root surface characteristics after instrumentation were examined using scanning electron microscopy, and the amount of remaining calculus, roughness and loss of tooth substance were estimated using the remaining calculus index and roughness loss of tooth substance index. Results:, The remaining calculus index did not differ significantly among the three groups. The roughness loss of tooth substance index was significantly lower for the VectorÔ scaler and Enac® scaler groups than for the hand scaler group and also differed significantly between the VectorÔ scaler and Enac® scaler groups. Conclusion:, This study suggests that the VectorÔ scaler produces a smooth root surface with minimal loss of tooth substance. It is a reasonable choice for gentle periodontal maintenance treatment. [source] | ||||||||||